Clinical trial
A Study of the Absorption of GT267-004 in Patients With Clostridium…
NCT00382304 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00382304 |
|---|---|
| Title | A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea |
| Official title | A Study of the Pharmacokinetics of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pseudomembranous Colitis, Clostridium Difficile Diarrhea, Antibiotic-Associated Diarrhea |
| Intervention type | Drug |
| Interventions | tolevamer potassium-sodium (GT267-004) |
| Enrollment | 24 |
| Start date | Sep 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Sep 29, 2006 |
| Last update posted | Mar 19, 2015 |
| Countries | Canada |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: